Table 1 Patients and treatment characteristics
Patients (n = 20) | |
Sex | |
Men | 35% (n = 7) |
Women | 65% (n = 13) |
Median age (years), (range) | 66 (48–76) |
Primary cancer | |
Breast | 50% (n = 10) |
Prostate | 25% (n = 5) |
Lung | 20% (n = 4) |
Small bowel | 5% (n = 1) |
Histological types | |
Adenocarcinoma | 55% (n = 11) |
Infiltrating ductal carcinoma | 35% (n = 7) |
Infiltrating lobular carcinoma | 5% (n = 1) |
Neuro-endocrine tumor | 5% (n = 1) |
Vertebral lesions | 22 |
Vertebrae treated in post-operative situation | 1 |
Location of spinal lesions | |
Thoracic spine | 55% (n = 12) |
Lumbar spine | 41% (n = 9) |
Sacrum | 4% (n = 1) |
Treatment | |
Mean GTV (cm3), (range) | 9.96 (0.40–42.30) |
Mean CTV (cm3), (range) | 32.35 (8.74–99.50) |
Prescribed dose | |
5 × 7 Gy | 100% (n = 20) |